Yourway Cannabis Brands Stock EBITDA
YourWay Cannabis Brands fundamentals help investors to digest information that contributes to YourWay Cannabis' financial success or failures. It also enables traders to predict the movement of YourWay Pink Sheet. The fundamental analysis module provides a way to measure YourWay Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to YourWay Cannabis pink sheet.
YourWay |
YourWay Cannabis Brands Company EBITDA Analysis
YourWay Cannabis' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current YourWay Cannabis EBITDA | (1.02 M) |
Most of YourWay Cannabis' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, YourWay Cannabis Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, YourWay Cannabis Brands reported earnings before interest,tax, depreciation and amortization of (1.02 Million). This is 100.12% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 100.03% higher than that of the company.
YourWay EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses YourWay Cannabis' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of YourWay Cannabis could also be used in its relative valuation, which is a method of valuing YourWay Cannabis by comparing valuation metrics of similar companies.YourWay Cannabis is currently under evaluation in ebitda category among its peers.
YourWay Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 7.97 M | |||
| Shares Outstanding | 269.88 M | |||
| Shares Owned By Insiders | 55.45 % | |||
| Shares Owned By Institutions | 0.05 % | |||
| Price To Earning | 4.17 X | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.21 X | |||
| Revenue | 30.58 M | |||
| Gross Profit | 3.13 M | |||
| EBITDA | (1.02 M) | |||
| Net Income | (3.57 M) | |||
| Cash And Equivalents | 7.66 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 31.37 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 2.67 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (254.53 K) | |||
| Earnings Per Share | 0.01 X | |||
| Beta | 3.05 | |||
| Market Capitalization | 17.79 M | |||
| Total Asset | 14.83 M | |||
| Net Asset | 14.83 M |
About YourWay Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze YourWay Cannabis Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YourWay Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YourWay Cannabis Brands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in YourWay Pink Sheet
YourWay Cannabis financial ratios help investors to determine whether YourWay Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in YourWay with respect to the benefits of owning YourWay Cannabis security.